IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia
Eileen M. Boyle(BMW (Germany)), Xavier Leleu(Inserm), Hélène Demarquette(Ikerbasque), Thierry Façon(Université de Lille), Sarah Bonnet(Hôpital Saint Eloi), Guillemette Fouquet(Centre Hospitalier Universitaire de Lille), Salomon Manier(Université de Lille), Stéphanie Guidez(Inserm), Sylvie Chevret(Saint Louis University Hospital), Houria Debarri(Centre Hospitalier Universitaire de Lille), Julie Gay(Centre Hospitalier de la Côte Basque), Hervé Avet‐Loiseau(Institut universitaire du cancer de Toulouse Oncopole), Bernadette Hennache(Université de Lille), Rémy Duléry(Dana-Farber Cancer Institute), Brigitte Onraed, Julie Lejeune(Délégation Paris 7), Stephen Harding, Jean‐Luc Faucompré(Université de Lille), Véronique Leblond(Sorbonne Université), Susanna Schraen‐Maschke(Université de Lille)
Cited by 10
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
|Nature Communications|2014|906